Analgesics (Pharmacies) - Serbia | Statista Market Forecast

Revenue in the Analgesics market is projected to reach US$81.02m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 9.86%, resulting in a market volume of US$129.70m by 2029.
In global comparison, most revenue will be generated China (US$5.03bn in 2024).
In relation to total population figures, per person revenues of US$11.42 are generated in 2024.

Definition:
The Analgesics market encompasses non-prescription natural and synthetic non-opioid analgesics sold through pharmacies. These include well-known products such as Paracetamol, Ibuprofen, Aspirin, Diclofenac, and various pain-relieving preparations. The market's scope varies with national legislation concerning opioid analgesics, with legal opioids being incorporated based on respective state regulations. In countries like Germany, Austria, and Switzerland, opioid analgesics are included if they comply with narcotics law limitations and do not necessitate a prescription. The analgesics are presented in forms like pills, capsules, gels, and ointments. However, the market excludes prescription medications (e.g., morphine), anesthetics, and homeopathic remedies. Notable top-selling painkillers encompass Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol, and ASS. This market exclusively covers product sales through pharmacies.

Additional information:
The Analgesics market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics (Pharmacies) market in Serbia has been experiencing steady growth in recent years.

Customer preferences: Serbian consumers have shown a growing preference for analgesics purchased from pharmacies rather than other retail outlets. This is primarily due to the perception that pharmacies offer a wider range of high-quality products and professional advice from pharmacists. Additionally, consumers in Serbia tend to trust pharmacies more than other types of stores when it comes to purchasing medications.

Trends in the market: One of the key trends in the Analgesics (Pharmacies) market in Serbia is the increasing demand for over-the-counter (OTC) analgesics. This can be attributed to several factors, including the rising prevalence of chronic pain conditions and the growing awareness of self-medication among consumers. OTC analgesics are more convenient and accessible for consumers, as they do not require a prescription and can be purchased directly from pharmacies. Another trend in the market is the growing popularity of natural and herbal analgesics. Serbian consumers are becoming more health-conscious and are seeking alternative remedies for pain relief. This trend is in line with the global shift towards natural and organic products, as consumers are increasingly concerned about the potential side effects of conventional analgesics.

Local special circumstances: One of the unique aspects of the Analgesics (Pharmacies) market in Serbia is the strong presence of traditional medicine. Traditional remedies, such as herbal teas and balms, are widely used by Serbian consumers for pain relief. This preference for traditional medicine is deeply rooted in the country's cultural heritage and is often passed down through generations. As a result, pharmacies in Serbia often stock a wide range of traditional analgesics alongside conventional products.

Underlying macroeconomic factors: The growth of the Analgesics (Pharmacies) market in Serbia can be attributed to several macroeconomic factors. The country's improving economic conditions have led to higher disposable incomes, allowing consumers to spend more on healthcare products. Additionally, the aging population in Serbia has contributed to the increased demand for analgesics, as older individuals are more likely to experience chronic pain and require pain management solutions. In conclusion, the Analgesics (Pharmacies) market in Serbia is developing due to customer preferences for pharmacy purchases, the increasing demand for OTC analgesics, the popularity of natural and herbal remedies, the strong presence of traditional medicine, and underlying macroeconomic factors such as improving economic conditions and an aging population.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.